1,4-Dioxa-7-azaspiro[4.4]nonane

Catalog No. :
ACZITQ216
CAS No. :
176-33-0
Molecular Formula :
C6H11NO2
Molecular Weight :
129.16

IUPAC Name:1,4-dioxa-7-azaspiro[4.4]nonane

1,4-Dioxa-7-azaspiro[4.4]nonane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$55.00Login to see priceIn stockInquiry
250mg98%$84.00Login to see priceIn stockIn stock
1g98%$195.00Login to see priceIn stockIn stock
5g98%$641.00Login to see priceIn stockIn stock
25g98%$2548.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,4-Dioxa-7-azaspiro[4.4]nonane
IUPAC Name1,4-dioxa-7-azaspiro[4.4]nonane
MDL No.MFCD09833560
Molecular FormulaC6H11NO2
Molecular Weight129.16
SMILESC12(OCCO1)CCNC2
InChI KeyJTOUWLZSXWMCSH-UHFFFAOYSA-N
SynonymEN300-66175 | CS-0217019 | BS-35781 | JTOUWLZSXWMCSH-UHFFFAOYSA-N | 1,4-dioxa-7-azaspiro[4.4]nonane | 1,4-Dioxa-7-aza-spiro[4.4]nonane | DTXSID90569419 | 1,4-Dioxa-7-azaspiro[4.4]nonane, AldrichCPR | AT11217 | FT-0723106 | A846185 | AKOS004911111 | MFCD09
CAS No.176-33-0
PubChem CID15165039

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H315-H318-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACZITQ216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZITQ216 route product structure diagram
    ACZITQ216176-33-0 In Stock
Inquiry

2. ACZITQ216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACZITQ216 route product structure diagram
    ACZITQ216176-33-0 In Stock
Inquiry

Comments (0)